Nexalin Technology Inc.
Organization details
- Legal name
- Nexalin Technology Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3845 — Electromedical & Electrotherapeutic Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Houston
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NXL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001527352
- EIN
- 27-5566468
Board of directors
-
Alan Kazden · DirectorSince 2023
-
Ben Hu · DirectorSince 2022
-
David Owens · Director · Chief Medical OfficerSince 2023
-
Leslie Bernhard · DirectorSince 2024
-
Mark White · Director · CEOSince 2023
-
Rick Morad · DirectorSince 2022
Chief executives
Director election results
Annual meeting of July 16, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
100.0%
-
100.0%
-
100.0%
-
100.0%
-
100.0%
Board connections
1 of this board's directors also sit on 2 other boards.
- via Leslie Bernhard
- via Leslie Bernhard
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 29, 2025 | Leonard Osser 10% owner | Grant or award | +83,333 | — | — |
| Sep 29, 2025 | David Owens Director, Officer (Chief Medical Officer) | Grant or award | +36,459 | — | — |
| Sep 29, 2025 | Ben Hu Director | Grant or award | +36,459 | — | — |
| Sep 29, 2025 | Alan Kazden Director | Grant or award | +36,459 | — | — |
| Mar 12, 2025 | Shelton Carolyn Hamby Officer (Sr. VP - Quality, Regulatory) | Open-market purchase | +6,000 | $2.20 | $13,200 |
| Feb 4, 2025 | David Owens Director, Officer (Chief Medical Officer) | Open-market purchase | +1,000 | $3.10 | $3,100 |
| Feb 4, 2025 | David Owens Director, Officer (Chief Medical Officer) | Open-market purchase | +1,000 | $2.98 | $2,980 |
| Jan 28, 2025 | David Owens Director, Officer (Chief Medical Officer) | Open-market purchase | +1,500 | $2.70 | $4,050 |
| Jan 23, 2025 | David Owens Director, Officer (Chief Medical Officer) | Open-market purchase | +1,000 | $2.70 | $2,700 |
| Jan 13, 2025 | David Owens Director, Officer (Chief Medical Officer) | Open-market purchase | +2,000 | $2.50 | $5,000 |
| Dec 20, 2024 | David Owens Director, Officer (Chief Medical Officer) | Open-market purchase | +1,000 | $2.75 | $2,750 |
| Oct 28, 2024 | David Owens Director, Officer (Chief Medical Officer) | Open-market purchase | +500 | $2.19 | $1,095 |
| Oct 14, 2024 | Shelton Carolyn Hamby Officer (Senior VP) | Open-market purchase | +24,000 | $0.85 | $20,400 |
| Sep 30, 2024 | Leslie Bernhard Director | Grant or award | +49,838 | — | — |
| Sep 30, 2024 | Ben Hu Director | Grant or award | +175,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Nexalin Technology Inc.
Who is the CEO of Nexalin Technology Inc.?
Mark White is Nexalin Technology Inc.'s President/CEO.
How many directors are on Nexalin Technology Inc.'s board?
Nexalin Technology Inc.'s board has 6 directors: Alan Kazden, Ben Hu, David Owens, Leslie Bernhard, Mark White and Rick Morad.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="nexalin-technology-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.